Consumer News Fda Approves First Digital Treatment For Depression
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Fda Approves First Digital Treatment For Depression is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
FDA approves Caplyta for major depressive disorder in adults
The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. Read More
FDA’s Digital Health Advisory Committee Considers Generative AI Therapy Chatbots for Depression
While the FDA has approved digital mental health solutions in recent years, including apps with solutions involving cognitive behavioral therapy (CBT), the agency has yet to clear mental health tools ... Read More
Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression
Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus